Table 1 Baseline patient characteristics of study patients
All N = 63 | No VT/VTE N = 34 | VT/VTE N = 29 | p | |
|---|---|---|---|---|
General characteristics | ||||
Survivors | 42 (66.7) | 24 (70.6) | 18 (62.1) | 0.594 |
Male (%) | 37 (58.7) | 22 (59.5) | 15 (40.5) | 0.318 |
Age (years) | 46.0 ± 14.4 | 47.6 ± 13.7 | 44.2 ± 15.3 | 0.465 |
Height (cm) | 169.9 ± 9.7 | 168.8 ± 7.9 | 171.1 ± 11.6 | 0.451 |
Weight | 70.9 ± 25.6 | 69.9 ± 25.2 | 72.1 ± 26.4 | 0.778 |
BMI | 28.3 ± 9.8 | 27.7 ± 9.5 | 28.0 ± 10.3 | 0.390 |
CVVHD (%) | 33 (52.4) | 16 (47.1) | 17 (58.6) | 0.450 |
Time on ECMO (days) | 22.4 ± 17.4 | 17.9 ± 13.9 | 27.7 ± 19.7 | 0.040 |
Cannulation | ||||
VJI/VF | 52 (82.5) | 27 (79.4) | 25 (86.2) | 0.526 |
BCDL cannula | 11 (17.5) | 7 (20.6) | 4 (13.8) | |
Underlying disease | ||||
ARDS (%) | 34 (54.0) | 19 (55.8) | 15 (51.7) | |
Pulmonary (%) | 33 (97.0) | 18 (52.9) | 15 (51.7) | |
Extrapulmonary (%) | 1 (3) | 1 (2.9) | 0 (0) | |
Bridge to LTX (%) | 29 (46.0) | 15 (44.1) | 14 (48.3) | |
CF (%) | 10 (15.9) | 6 (17.6) | 4 (13.8) | |
COPD (%) | 4 (6.3) | 2 (5.8) | 2 (6.9) | |
ILD (%) | 14 (22.2) | 7 (20.6) | 7 (24.1) | |
PH (%) | 1 (1.6) | 1 (2.9) | 0 (0) | |